Mini Oral - Genitourinary tumours, prostate
Invited Discussant 615MO and 616MO
Date
18 Sep 2020Session
Mini Oral - Genitourinary tumours, prostatePresenters
Andrea AlimontiAuthors
A. AlimontiAuthor affiliations
- Molecular Oncology Department, EOC - Ospedale Regionale Bellinzona e Valli - Istituto Oncologico della Svizzera Italiana (IOSI), 6500 - Bellinzona/CH
Resources
Resources from the same session
612MO - Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
Presenter: Rebeca Lozano Mejorada
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
614MO - Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects
Presenter: Mihaela Aldea
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
LBA22 - Imaging based PCa screening among BRCA mutation carriers: Results from the first round of screening
Presenter: David Margel
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
615MO - Phase Ib/II study of VERU-111, novel, oral tubulin inhibitor, in men with metastatic castration resistant prostate cancer (mCRPC) who failed an androgen blocking agent
Presenter: Mark Markowski
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
616MO - Efficacy of BN-brachyury (BNVax) + bintrafusp alfa (BA) + N-803 in castration-resistant prostate cancer (CRPC): Results from a preliminary analysis of the Quick Efficacy Seeking Trial (QuEST1)
Presenter: Jason Redman
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
617MO - Repurposing metformin as an anticancer drug: Preliminary results of randomized controlled trial in advanced prostate cancer (MANSMED)
Presenter: Reham Alghandour
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
618MO - Local therapy to the primary tumour for newly diagnosed, oligo-metastatic prostate cancer: A prospective randomized, phase II, open-label trial
Presenter: Bo Dai
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Open & welcome
Presenter: Eleni Efstathiou
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Webcast
Invited Discussant 612MO, 614MO and LBA22
Presenter: Eleni Efstathiou
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Webcast
Invited Discussant 617MO and 618MO
Presenter: Noel Clarke
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Slides
Webcast